The HIST1H3A gene (Gene ID: P68431) encodes a core histone H3.1 variant involved in nucleosome assembly. The K122 modification represents a recently identified acylation type linked to metabolic regulation and epigenetic signaling .
Key features of the modification site:
Structural role: Located in the globular core of histone H3, K122 participates in DNA-histone interactions.
Functional impact: 2-hydroxyisobutyrylation at this site correlates with transcriptional activation and chromatin relaxation .
Validated uses across experimental platforms:
Specificity Controls: Recommended to use histone extracts from HeLa cells treated with histone deacylase inhibitors as positive controls .
Interference Risks: No observed cross-reactivity with acetylated or methylated H3K122 variants in validation studies .
Batch Consistency: ≥90% inter-batch reproducibility reported by manufacturers .
2-hydroxyisobutyrylation is a post-translational modification (PTM) of histones that plays a crucial role in epigenetic regulation. This modification occurs at specific lysine residues on histone proteins, including H3, and contributes to chromatin structure modulation and gene expression regulation. In the context of HIST1H3A, 2-hydroxyisobutyrylation at lysine positions (such as K18 or K122) represents an important epigenetic mark that researchers study to understand chromatin dynamics and transcriptional control mechanisms. This modification is part of the expanding "histone code" that determines genome function beyond the DNA sequence itself .
The key difference between these antibodies is their target epitope specificity - they recognize 2-hydroxyisobutyryl modifications at distinct lysine positions on the histone H3.1 protein. The K18 antibody targets the modification at lysine 18, while the K122 antibody specifically recognizes the modification at lysine 122. These different lysine positions are located in distinct regions of the histone protein and likely serve different functional roles in chromatin regulation. The immunogens used to develop these antibodies contain peptide sequences surrounding the specifically modified lysine residue (K18 or K122) derived from human histone H3.1 . Researchers should select the appropriate antibody based on which specific modification site they need to investigate for their particular epigenetic research question.
2-hydroxyisobutyryl-HIST1H3A antibodies have been validated for multiple experimental applications:
| Application | Description | Recommended Dilution |
|---|---|---|
| Western Blot (WB) | Detection of protein expression levels | 1:100-1:1000 |
| Immunocytochemistry (ICC) | Cellular localization studies | 1:20-1:200 |
| Immunofluorescence (IF) | Visualization of target in fixed cells | 1:10-1:100 |
| Chromatin Immunoprecipitation (ChIP) | Analysis of protein-DNA interactions | As specified in protocols |
| ELISA | Quantification in solution | As specified in protocols |
For optimal results across these applications, researchers should perform careful antibody titration experiments to determine the ideal concentration for their specific sample type and experimental conditions. Western blotting typically yields excellent quantitative results for measuring global changes in histone modifications, while ChIP provides insights into genomic localization of the modifications .
Based on protocols established for histone modification analysis, a flow cytometry approach can be adapted for 2-hydroxyisobutyryl-HIST1H3A detection. The method involves:
Cell fixation with formaldehyde (typically 1-4%) for 10-15 minutes at room temperature
Permeabilization with ice-cold 90% methanol for 30 minutes
Blocking with PBS containing 0.5% BSA for 10 minutes
Incubation with primary 2-hydroxyisobutyryl-HIST1H3A antibody (1:50-1:200 dilution) for 1 hour
Washing with PBS containing 0.5% BSA (3×)
Incubation with fluorophore-conjugated secondary antibody for 30 minutes
Final washing and analysis by flow cytometry
Flow cytometry offers advantages for quantitative assessment of histone modifications in individual cells and can detect relative differences in modification levels with high sensitivity. Studies have shown that flow cytometry may provide superior quantitative results compared to western blotting for monitoring histone modifications in certain contexts .
To maintain the integrity of 2-hydroxyisobutyryl modifications for reliable antibody detection:
Sample Collection: Harvest cells or tissues rapidly and process immediately to prevent loss of modifications
Fixation: Use freshly prepared fixatives (4% paraformaldehyde or formaldehyde) when applicable
Protein Extraction: Include HDAC inhibitors (e.g., sodium butyrate) and protease inhibitors in lysis buffers
Storage Conditions:
Short-term (≤1 week): 4°C in appropriate buffer with preservatives
Long-term: -20°C or -80°C with 50% glycerol and protective agents (0.03% Proclin 300, 0.01M PBS, pH 7.4)
Avoid repeated freeze-thaw cycles
Research has shown that histone modifications can be reliably detected for up to 96 hours at various temperatures (4°C, 20°C, or 37°C), though stability decreases significantly after 96 hours at 37°C. For optimal results, analyze samples as soon as possible after collection, especially when quantitative comparisons are critical .
The preservation of lysine 122 modifications requires specific attention due to its location in the C-terminal region of histone H3, which may affect accessibility and stability differently than modifications at other sites like K18:
Extraction Methods: Use specialized histone extraction protocols that maintain the integrity of the histone C-terminal domain
Buffer Composition: Include deacetylase inhibitors specific to the enzymes that target K122 modifications
Sample Processing Time: Minimize processing time to prevent enzymatic removal of the modifications
Denaturing Conditions: Adjust denaturing conditions during western blotting procedures to ensure proper epitope exposure
Fixation Parameters: For immunofluorescence or ChIP applications, optimize fixation parameters specifically for K122 accessibility
These considerations are particularly important since the dynamics and stability of different histone modifications can vary based on their position within the histone protein and their functional roles in chromatin regulation .
To investigate modification crosstalk using 2-hydroxyisobutyryl-HIST1H3A antibodies:
Sequential ChIP (Re-ChIP): Perform initial ChIP with 2-hydroxyisobutyryl-HIST1H3A antibody, followed by a second immunoprecipitation with antibodies against other modifications to identify co-occurrence patterns
Mass Spectrometry Integration: Combine antibody-based enrichment with mass spectrometry to identify and quantify multiple modifications on the same histone molecules
Proximity Ligation Assays: Detect spatial proximity between 2-hydroxyisobutyryl modifications and other histone marks within the same nucleosome
Combinatorial Immunofluorescence: Use multiplexed immunofluorescence with antibodies against different modifications to assess correlation patterns
Genome-wide ChIP-seq Analysis: Compare ChIP-seq profiles of 2-hydroxyisobutyryl-HIST1H3A with other histone marks to identify regions of overlap or mutual exclusivity
This integrated approach can reveal functional relationships between 2-hydroxyisobutyryl modifications and other epigenetic marks such as acetylation, methylation, or phosphorylation, providing insights into the complex regulatory mechanisms of the histone code .
For effective multiplexing of 2-hydroxyisobutyryl-HIST1H3A antibodies with other histone modification antibodies:
Antibody Selection Criteria:
Choose antibodies raised in different host species to allow simultaneous detection
Verify absence of cross-reactivity between antibodies
Select antibodies with compatible working dilutions
Fluorophore Combination Strategies:
Use fluorophores with minimal spectral overlap
Apply appropriate compensation controls
Consider brightness hierarchy based on expected target abundance
Sequential Staining Protocols:
Block between sequential antibody applications
Consider mild stripping between applications if necessary
Optimize order of antibody application to minimize interference
Validation Approaches:
Perform single-antibody controls alongside multiplexed experiments
Include biological controls with known modification patterns
Validate results using alternative techniques
By carefully implementing these strategies, researchers can simultaneously analyze multiple histone modifications, enabling more comprehensive insights into the complex relationships within the epigenetic landscape .
Common sources of non-specific binding and their mitigation strategies include:
| Source of Non-specificity | Mitigation Strategy |
|---|---|
| Cross-reactivity with similar modifications | Use highly purified antibodies validated for specificity |
| Insufficient blocking | Increase blocking time/concentration; use alternative blocking agents (BSA, normal serum, casein) |
| Excessive antibody concentration | Titrate antibody to optimal concentration; perform dilution series |
| Sample over-fixation | Optimize fixation time and conditions; consider antigen retrieval |
| Protein aggregation | Improve sample preparation; include detergents in washing buffers |
| Secondary antibody issues | Include secondary-only controls; use cross-adsorbed secondary antibodies |
Additionally, researchers should incorporate proper controls including:
No primary antibody control
Peptide competition assays with modified and unmodified peptides
Samples with known modification status (positive and negative controls)
These measures help ensure that the observed signals are specific to the 2-hydroxyisobutyryl modification at the intended lysine position (K122 or K18) .
To validate antibody specificity for 2-hydroxyisobutyryl-HIST1H3A in a specific experimental system:
Peptide Competition Assays:
Pre-incubate antibody with excess modified peptide (containing 2-hydroxyisobutyryl-K122 or K18)
Pre-incubate with unmodified peptide as control
Observe signal reduction only with the modified peptide
Modification Enzyme Manipulation:
Treat samples with HDAC inhibitors to increase modification levels
Compare signal intensity before and after treatment
Observe expected changes in signal intensity
Knockdown/Knockout Validation:
Deplete enzymes responsible for 2-hydroxyisobutyryl modification
Confirm reduction in signal using the antibody
Mass Spectrometry Correlation:
Analyze samples by both antibody-based detection and mass spectrometry
Confirm correlation between methods for modification abundance
Signal Localization Analysis:
Verify nuclear localization consistent with histone proteins
Confirm expected pattern distribution in chromatin
This comprehensive validation ensures that the antibody specifically recognizes the 2-hydroxyisobutyryl modification at the correct lysine residue in the particular experimental context .
Methodological comparison between 2-hydroxyisobutyryl-HIST1H3A and other histone H3 modifications:
| Aspect | 2-hydroxyisobutyryl-HIST1H3A | Acetylation | Methylation | Phosphorylation |
|---|---|---|---|---|
| Antibody Specificity | Site and modification-specific | Site-specific, potential cross-reactivity between acetylation sites | Site and methylation state-specific (mono, di, tri) | Site-specific, often phosphorylation-state dependent |
| Detection Sensitivity | Comparable to acetylation | High sensitivity, well-established | Variant-dependent | Often requires phosphatase inhibitors |
| Western Blot Conditions | Standard conditions with careful blocking | Standard conditions | Standard conditions | Phosphatase inhibitors required |
| ChIP Efficiency | Comparable to acetylation | High efficiency, gold standard | Modification-state dependent | Often lower efficiency |
| Flow Cytometry Application | Effective with proper permeabilization | Well-established method | Effective with proper controls | Requires special fixation |
| Stability During Processing | Moderately stable | Relatively stable | Very stable | Less stable, easily lost |
For optimal results across modification types, flow cytometry has proven particularly effective for quantitative analysis, offering superior sensitivity compared to western blotting in some contexts. Research has demonstrated that histone H3 modifications can be reliably detected across various storage conditions, though stability decreases significantly after prolonged storage at higher temperatures .
Emerging applications of 2-hydroxyisobutyryl-HIST1H3A antibodies in multi-omics research include:
Epigenome-Transcriptome Integration:
ChIP-seq with 2-hydroxyisobutyryl-HIST1H3A antibodies combined with RNA-seq
Correlation of 2-hydroxyisobutyryl modification patterns with gene expression profiles
Identification of regulatory elements marked by this modification
Chromatin Accessibility Correlation:
Integration of ChIP-seq data with ATAC-seq or DNase-seq
Analysis of 2-hydroxyisobutyryl modification enrichment at open chromatin regions
Characterization of chromatin state transitions associated with this modification
Protein Interaction Networks:
Identification of reader proteins that specifically recognize 2-hydroxyisobutyryl modifications
Characterization of writer and eraser enzymes regulating this modification
Mapping of interaction networks associated with modified histones
Single-Cell Applications:
Adaptation of antibodies for single-cell ChIP or CUT&Tag protocols
Integration with single-cell transcriptomics and proteomics
Characterization of cellular heterogeneity in modification patterns
These integrated approaches provide comprehensive insights into the functional role of 2-hydroxyisobutyryl modifications in chromatin biology and gene regulation, positioning this modification within the broader context of epigenetic regulation mechanisms .